Chemical compounds
    3.
    发明授权
    Chemical compounds 有权
    化合物

    公开(公告)号:US07119092B2

    公开(公告)日:2006-10-10

    申请号:US10398264

    申请日:2001-10-12

    IPC分类号: A61K31/496 C07D401/04

    CPC分类号: A61K31/496 C07D211/58

    摘要: wherein R represents a halogen atom or a C1-4 alkyl group; R1 represents a C1-4 alkyl group; R2 represents hydrogen or a C1-4 alkyl group; R3 represents hydrogen, or a C1-4 alkyl group; R4 represents a trifluoromethyl group; R5 represents hydrogen, a C1-4 alkyl group or C(O)R6; R6 represents C1-4 alkyl, C3-7 cycloalkyl, NH(C1-4 alkyl) or N(C1-4alkyl)2; m is zero or an integer from 1 to 3; n is an integer from 1 to 3 and pharmaceutically acceptable salts and solvates thereof; to processes for their preparation and their use in the treatment of conditions mediated by tachykinins.

    摘要翻译: 其中R表示卤素原子或C 1-4烷基; R 1表示C 1-4烷基; R 2表示氢或C 1-4烷基; R 3表示氢或C 1-4烷基; R 4表示三氟甲基; R 5表示氢,C 1-4烷基或C(O)R 6; R 6表示C 1-4烷基,C 3-7环烷基,NH(C 1-4烷基) )或N(C 1-4烷基)2。 m为0或1〜3的整数; n为1〜3的整数及其药学上可接受的盐和溶剂合物; 其制备方法及其用于治疗由速激肽介导的病症。

    Chemical compounds
    6.
    发明授权
    Chemical compounds 有权
    化合物

    公开(公告)号:US07060702B2

    公开(公告)日:2006-06-13

    申请号:US10994605

    申请日:2004-11-22

    IPC分类号: A61K31/496 C07D401/04

    CPC分类号: A61K31/496 C07D211/58

    摘要: The present invention provides compounds of formula (I): wherein each R independently represents a halogen atom or a C1-4 alkyl group; R1 represents a C1-4 alkyl group; R2 represents hydrogen or a C1-4 alkyl group; R3 represents hydrogen or C1-4 alkyl group; R4 represents a trifluoromethyl group; R5 represents hydrogen, a C1-4 alkyl group or C(O)R6; R6 represents C1-4 alkyl, C3-7 cycloalkyl, NH(C1-4 alkyl) or N(C1-4alkyl)2; m is zero or an integer from 1 to 3; n is an integer from 1 to 3; or a pharmaceutically acceptable salt or solvate thereof; compositions containing the same, processes for their preparation and methods for their use in the treatment of conditions mediated by tachykinins.

    摘要翻译: 本发明提供式(I)化合物:其中每个R独立地表示卤素原子或C 1-4烷基; R 1表示C 1-4烷基; R 2表示氢或C 1-4烷基; R 3表示氢或C 1-4烷基; R 4表示三氟甲基; R 5表示氢,C 1-4烷基或C(O)R 6; R 6表示C 1-4烷基,C 3-7环烷基,NH(C 1-4烷基) )或N(C 1-4烷基)2。 m为0或1〜3的整数; n为1〜3的整数, 或其药学上可接受的盐或溶剂化物; 含有它们的组合物,其制备方法和用于治疗由速激肽介导的病症使用的方法。

    Process for preparing dorzolamide
    8.
    发明授权
    Process for preparing dorzolamide 失效
    制备多佐胺的方法

    公开(公告)号:US08183391B2

    公开(公告)日:2012-05-22

    申请号:US12296834

    申请日:2007-04-16

    IPC分类号: C07D333/34 A61K31/38

    CPC分类号: C07D495/04

    摘要: A process for resolving dorzolamide trans racemate, which comprises reacting said racemate with (1S)-(+)-10-camphorsulfonic acid so obtaining the (4S,6S) enantiomer by selectively precipitating and recovering the camphorsulfonic acid salt thereof (dorzolamide camphorsulfonate), and neutralizing dorzolamide camphorsulfonate to obtain dorzolamide.

    摘要翻译: 一种解决多佐胺反式外消旋体的方法,其包括使所述外消旋体与(1S) - (+) - 10-樟脑磺酸反应,从而通过选择性沉淀并回收其樟脑磺酸盐(多佐胺樟脑磺酸盐),得到(4S,6S) 并中和多佐胺樟脑磺酸盐,得到多佐胺。

    PROCESS FOR PREPARING NEBIVOLOL
    9.
    发明申请
    PROCESS FOR PREPARING NEBIVOLOL 有权
    制备NEBIVOLOL的方法

    公开(公告)号:US20110021793A1

    公开(公告)日:2011-01-27

    申请号:US12935150

    申请日:2009-03-16

    IPC分类号: C07D311/04

    CPC分类号: C07D311/58 C07D407/04

    摘要: The present invention relates to a process for reducing a compound of formula (I) wherein X is halogen, a hydroxy group, an alkylsulfoniloxy group or an arylsulfonyloxy group; to give a compound of formula (II) as a di-astereoisomerically pure compound of RS/SR configuration characterized in that said reduction is carried out by the use of (+)-B-chlorodiisopinocampheylborane or (−)-B-chlorodiisopinocampheylborane. The compounds of formula (II) are useful as intermediates for the preparation of Nebivolol.

    摘要翻译: 本发明涉及还原式(I)化合物的方法,其中X为卤素,羟基,烷基磺酰氧基或芳基磺酰氧基; 得到式(II)的化合物,其为双偶联纯的RS / SR构型化合物,其特征在于所述还原是通过使用(+) - B-氯二氧杂环己烷基硼烷或( - ) - B-氯二氧杂环己烷基硼烷来进行的。 式(II)化合物可用作制备奈比洛尔的中间体。